These cells are activated by tumor-derived angiogenic factors such as vascular endothelial growth factor (VEGF) and angiopoietins, leading to abnormal vascular networks that also enable immune evasion (Patel et al., 2023; Han et al., 2025). The gene discussed is VEGFA; the disease is neoplasm.